DelveInsight

DelveInsight, a prominent business consulting and market research firm, distinguishes itself by seamlessly merging industry expertise with insightful market analysis methodologies to furnish crucial insights to top-tier decision-makers. The organization's mission centers around assisting its clientele in the acquisition of pertinent information, thereby enhancing their decision-making capabilities. DelveInsight is adept at recognizing potential market opportunities, conducting competitor assessments, and undertaking comprehensive evaluations of the business environment. Notably, DelveInsight serves as a trusted and informed partner, offering invaluable support in shaping business strategies and conducting market research across the entire drug value chain.

DelveInsight's primary conduit for delivering intelligent information to professionals in both the business and healthcare sectors is through its meticulously crafted analytical and strategic reports. Presently, DelveInsight boasts a diverse portfolio encompassing over 3,000 Marketed and Pipeline Reports. These reports are thoughtfully categorized based on parameters such as indication, mechanism of actions, drugs, global API manufacturers, and specialized reports focusing on pivotal areas such as Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy, and other emerging domains. This robust platform has become the go-to resource for numerous enterprises seeking to transform and redefine their business strategies.

DelveInsight's offerings extend beyond reports to encompass Consulting Projects and Competitive Intelligence services, catering to the multifaceted needs of its clientele. Moreover, the organization is dedicated to providing tailor-made research services that align with the specific interests and requirements of its clients. DelveInsight's commitment to excellence and innovation positions it as a trusted partner in the areas of business strategy and market research.

View recent articles by this publisher on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
The Power of Digital Therapeutics in Mental Health
Anti-VEGF Therapies: Forever Market Rulers of Wet-AMD Treatment?
Additional articles from this publisher

...Show More ...Show Less

8,654 Reports from DelveInsight

Sort by:

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,250

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2024 DelveInsight’s, “Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 8+ pipeline drugs in Muscarinic Acetylcholine Receptor M1 Antagonists pipe ... Read More
Dementia Associated With Alzheimer’s Disease - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 3,000

Dementia Associated With Alzheimer’s Disease - Pipeline Insight, 2024 DelveInsight’s, “Dementia Associated With Alzheimer’s Disease - Pipeline Insight, 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Dementia Associated With Alzheimer’s Disease pipeline la ... Read More
Type 2 Diabetes - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 3,000

Type 2 Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Type 2 Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Type 2 Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
Niemann-Pick disease - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,500

Niemann-Pick disease - Pipeline Insight, 2024 DelveInsight’s, “Niemann-Pick disease - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Niemann-Pick disease pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More
Cutaneous T-cell lymphoma - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 2,000

Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
Synovial Sarcoma - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 2,000

Synovial Sarcoma - Pipeline Insight, 2024 DelveInsight’s, “Synovial Sarcoma- Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More
Wilson Disease- Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,250

Wilson Disease- Pipeline Insight, 2024 DelveInsight’s, “Wilson Disease- Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Wilson Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More
Alcohol Use Disorder - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 2,000

Alcohol Use Disorder - Pipeline Insight, 2024 DelveInsight’s, “Alcohol Use Disorder - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,500

Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024 DelveInsight’s, “Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Chronic Pseudomonas Aeruginosa Pulmonary In ... Read More
Polycystic Kidney Diseases - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,500

Polycystic Kidney Diseases - Pipeline Insight, 2024 DelveInsight’s, “Polycystic Kidney Diseases - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It covers the pipeline drug profiles, including ... Read More
Prostate Cancer - Competitive landscape, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 5,000

Prostate Cancer - Competitive landscape, 2024 DelveInsight’s, “Prostate Cancer - Competitive landscape, 2024,” report provides comprehensive insights about 230+ companies and 265+ drugs in Prostate Cancer Competitive landscape. It covers the therapeutics assessment by product type, stage, and route ... Read More
Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,500

Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2024 DelveInsight’s, “Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Non‐cystic fibrosis bronchiectasis pipeline landscape. It covers the pipeline ... Read More
Lupus Nephritis - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 2,000

Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
Familial adenomatous polyposis - Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,250

Familial adenomatous polyposis - Pipeline Insight, 2024 DelveInsight’s, “Familial adenomatous polyposis - Pipeline Insight, 2024” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Familial adenomatous polyposis pipeline landscape. It covers the pipeline drug profiles ... Read More
Smoking Cessation- Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,500

Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 1,500

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 DelveInsight’s, “Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Metastatic Triple-Negative Breast Cancer (mTNBC) pi ... Read More
Stargardt Disease (STGD)- Pipeline Insight, 2024

Nov 01, 2024 | Published by: DelveInsight | USD 2,000

Stargardt Disease (STGD)- Pipeline Insight, 2024 DelveInsight’s, “Stargardt Disease (STGD)- Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinic ... Read More
Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Neuromodulation Devices Market by Type (Invasive and Non-Invasive), Product (Spinal Cord Stimulators, Vagus Nerve Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Transcranial Magnetic Stimulat ... Read More
Plaque Modification Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Plaque Modification Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Plaque Modification Devices Market by Product Type (Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices, and Others), Application (Coronary Artery ... Read More
Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030 Implantable Infusion Pump Market by Application (Chronic Pain, Diabetes, Oncology, and Others], End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North Ameri ... Read More
Hernia Repair Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Hernia Repair Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Hernia Repair Devices Market by Product Type (Hernia Mesh [Synthetic Mesh and Biologic/Bioresorbable Mesh], Hernia Fixators [Tack Applicators, Staplers, Sutures, Glue Applicators]), Surgery Type (Inguinal Hern ... Read More
Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030 Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals ... Read More
Hemodynamic Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Hemodynamic Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030 Hemodynamic Monitoring Systems Market by Product (Systems and Disposables), Type (Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring, and Non-Invasive Hemodynamic Monitoring), ... Read More
Surgical Drainage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Surgical Drainage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Surgical Drainage Devices market by Type (Active [Jackson-Pratt Drains, Hemovac Drains, Blake Drains, Negative Pressure Wound Therapy, and Others], Passive [Penrose Drains and Others]), Application (Genera ... Read More
Ophthalmic Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030

Oct 01, 2024 | Published by: DelveInsight | USD 3,750

Ophthalmic Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030 Ophthalmic Lasers Market by Product Type (Argon Blue-Green Laser, ND: Yag Laser, Femtosecond Lasers, Krypton Red Laser, and Others), Application (Glaucoma, Diabetic Retinopathy, Cataracts, and Others), End-User (H ... Read More